-
BioVaxys Announces Non-Brokered Private Placement
prnasia
June 29, 2021
BioVaxys Technology Corp. is pleased to announce a non-brokered private placement consisting of up to 9,090,909 units at a price of $0.22 per Unit for total gross proceeds of up to approximately $2,000,000.
-
Hebron Announces $6.5 Million Private Placement
En-CPhI.CN
December 10, 2019
Hebron Technology Co., Ltd., a developer, manufacturer and installer of valves and pipe fittings for use in the pharmaceutical, biological, food and beverage, and ...
-
Helix BioPharma Corp. Closes Private Placement, Extends Period to Exercise Warrants and Provides Corporate Update
firstwordpharma
March 18, 2019
Helix BioPharma Corp. (TSX, FSE: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has closed a private placement financing for gross proc
-
Ironshore Pharmaceuticals Announces Closing of $200 Million Financing
firstwordpharma
January 25, 2017
Ironshore Pharmaceuticals & Development, Inc. ("Ironshore"), a wholly owned subsidiary of Highland Therapeutics Inc., today announced it has completed a US$200 million private placement of Senior Secured Notes due 2024.